Literature DB >> 21845400

The role of EMT in renal fibrosis.

Rosemarie M Carew1, Bo Wang, Phillip Kantharidis.   

Abstract

It is clear that the well-described phenomenon of epithelial-mesenchymal transition (EMT) plays a pivotal role in embryonic development, wound healing, tissue regeneration, organ fibrosis and cancer progression. EMTs have been classified into three subtypes based on the functional consequences and biomarker context in which they are encountered. This review will highlight findings on type II EMT as a direct contributor to the kidney myofibroblast population in the development of renal fibrosis, specifically in diabetic nephropathy, the signalling molecules and the pathways involved in type II EMT and changes in the expression of specific miRNA with the EMT process. These findings have provided new insights into the activation and development of EMT during disease processes and may lead to possible therapeutic interventions to suppress EMTs and potentially reverse organ fibrosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21845400     DOI: 10.1007/s00441-011-1227-1

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  97 in total

Review 1.  Epithelial-mesenchymal transition: An emerging target in tissue fibrosis.

Authors:  Meirong Li; Fuxin Luan; Yali Zhao; Haojie Hao; Yong Zhou; Weidong Han; Xiaobing Fu
Journal:  Exp Biol Med (Maywood)       Date:  2015-09-11

Review 2.  Make Precision Medicine Work for Chronic Kidney Disease.

Authors:  Ling Sun; Lu-Xi Zou; Mao-Jie Chen
Journal:  Med Princ Pract       Date:  2016-12-14       Impact factor: 1.927

3.  ATF6 pathway of unfolded protein response mediates advanced oxidation protein product-induced hypertrophy and epithelial-to-mesenchymal transition in HK-2 cells.

Authors:  Xun Tang; Xiujie Liang; Minhui Li; Tingting Guo; Na Duan; Yue Wang; Guang Rong; Lei Yang; Shaojie Zhang; Jun Zhang
Journal:  Mol Cell Biochem       Date:  2015-06-05       Impact factor: 3.396

4.  PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease.

Authors:  Yajuan Li; Qingsong Hu; Chunlai Li; Ke Liang; Yu Xiang; Heidi Hsiao; Tina K Nguyen; Peter K Park; Sergey D Egranov; Chandrashekar R Ambati; Nagireddy Putluri; David H Hawke; Leng Han; Mien-Chie Hung; Farhad R Danesh; Liuqing Yang; Chunru Lin
Journal:  J Clin Invest       Date:  2019-02-11       Impact factor: 14.808

Review 5.  Transition of mesothelial cell to fibroblast in peritoneal dialysis: EMT, stem cell or bystander?

Authors:  Yu Liu; Zheng Dong; Hong Liu; Jiefu Zhu; Fuyou Liu; Guochun Chen
Journal:  Perit Dial Int       Date:  2015 Jan-Feb       Impact factor: 1.756

Review 6.  Nucleotides and nucleoside signaling in the regulation of the epithelium to mesenchymal transition (EMT).

Authors:  A S Martínez-Ramírez; M Díaz-Muñoz; A Butanda-Ochoa; F G Vázquez-Cuevas
Journal:  Purinergic Signal       Date:  2016-11-29       Impact factor: 3.765

7.  Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.

Authors:  Min-Kyung Kang; Sin-Hye Park; Yean-Jung Choi; Daekeun Shin; Young-Hee Kang
Journal:  J Mol Med (Berl)       Date:  2015-06-11       Impact factor: 4.599

8.  Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells.

Authors:  Kathryn E Ware; Shivee Gilja; Shenghan Xu; Samantha Shetler; Mohit K Jolly; Xueyang Wang; Suzanne Bartholf Dewitt; Alexander J Hish; Sarah Jordan; William Eward; Herbert Levine; Andrew J Armstrong; Jason A Somarelli
Journal:  J Vis Exp       Date:  2017-04-07       Impact factor: 1.355

9.  Blockade of ERK1/2 by U0126 alleviates uric acid-induced EMT and tubular cell injury in rats with hyperuricemic nephropathy.

Authors:  Min Tao; Yingfeng Shi; Lunxian Tang; Yi Wang; Lu Fang; Wei Jiang; Tao Lin; Andong Qiu; Shougang Zhuang; Na Liu
Journal:  Am J Physiol Renal Physiol       Date:  2019-01-16

10.  Tripartite motif-containing 35 (TRIM35) is up-regulated in UUO-induced renal fibrosis animal model.

Authors:  Yu Chen; Yue Ding; Li-Ming Wang
Journal:  Histol Histopathol       Date:  2020-09-21       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.